• tyc7111cc太阳成集团

    洞察市场格局
    解锁药品研发情报

    免费客服电话

    18983288589
    医药数据查询

    【ChiCTR-IOR-17010484】保持ICU機械通氣危重病人四肢肌肉量

    基本信息
    登记号

    ChiCTR-IOR-17010484

    试验状态

    结束

    药物名称

    /

    药物类型

    /

    规范名称

    /

    首次公示信息日的期

    2017-01-19

    临床申请受理号

    /

    靶点

    /

    适应症

    Respiratory and cardiac

    试验通俗题目

    保持ICU機械通氣危重病人四肢肌肉量

    试验专业题目

    保持ICU機械通氣危重病人四肢肌肉量

    申办单位信息
    申请人联系人
    申请人名称
    联系人邮箱
    联系人邮编

    联系人通讯地址
    临床试验信息
    试验目的

    The present study aimed to (1) examine the effect of early neuromuscular electrical stimulation (NMES) on quadriceps and biceps muscles size (in terms of thickness and cross sectional area) in patients who are mechanically ventilated in intensive care unit (ICU), and (2) elevate the quality of life and functional status of those patients receiving NMES at ICU discharge and (3) quantify the ICU length of stay, hospital length of stay and number of patients who were diagnosed with ICU acquired weakness at ICU discharge.

    试验分类
    试验类型

    随机平行对照

    试验分期

    其它

    随机化

    Patients will be randomly assigned with one limb for NMES treatment by drawing lots and the other limb will act as a control without intervention.

    盲法

    /

    试验项目经费来源

    Self finance

    试验范围

    /

    目标入组人数

    49

    实际入组人数

    /

    第一例入组时间

    2015-10-01

    试验终止时间

    2017-03-31

    是否属于一致性

    /

    入选标准

    1. Adult patients at ICU who are on mechanical ventilator due to acute respiratory failure, trauma, sepsis, and acute coronary syndromes; 2. Cardiorespiratory stability: FiO2≤ 55% & noradrenaline ≤ 0.2 ug/kg/min.；

    排除标准

    1. Conditions contraindicated for NMES such as skin allergy, open wounds or superficial metal implants over stimulation sites, etc.; 2. Trauma or surgery of leg, pelvis, or lumbar spine; 3. Open abdominal wounds; 4. Extreme obesity (BMI > 35kg/m2); 5. Serious bedsore or venous ulcers; 6. Pre-existing diagnosis causing neuromuscular weakness; 7. Acute stroke, Status epilepticus; 8. Coagulation disorders (INR>1.5 or platelets < 50,000/mm3); 9. Psychiatric disorder or emotional instability; 10. Cardiorespiratory instability: - PaO2 <8.66kPa; - Minute ventilation >150mL/kg body weight; - Respiratory rate >30 BPM; - On vasopressive support (noradrenaline > 0.2μgkg-1.min-1, dobutamine > 8μg.kg-1.min-1). 11. Acute renal failure with increased serum creatinine level (normal result is 0.7 to 1.3 mg/dL for men and 0.6 to 1.1 mg/dL for women); 12. APACHE II score ≥ 30.；

    研究者信息
    研究负责人姓名
    试验机构

    香港理工大學伊麗莎白女王醫院理療科

    研究负责人电话
    研究负责人邮箱
    研究负责人邮编

    /

    联系人通讯地址

    香港理工大學伊麗莎白女王醫院理療科的其他临床试验

    更多

    最新临床资讯

    tyc7111cc太阳成集团企业版
    50亿+条医药数据随时查
    7天免费试用
    体验产品